第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
Xiao Yi,Wu Jiaying,Zhou Mi,et al.Orelabrutinib Plus R-CHOP Regimen in Treatment-Naive Patients with TP53-Mutated Diffuse Large B-Cell Lymphoma (DLBCL)[J].BLOOD.2023,142:doi:10.1182/blood-2023-177563.
APA:
Xiao, Yi,Wu, Jiaying,Zhou, Mi,Shang, Zhen&Zhu, Ming.(2023).Orelabrutinib Plus R-CHOP Regimen in Treatment-Naive Patients with TP53-Mutated Diffuse Large B-Cell Lymphoma (DLBCL).BLOOD,142,
MLA:
Xiao, Yi,et al."Orelabrutinib Plus R-CHOP Regimen in Treatment-Naive Patients with TP53-Mutated Diffuse Large B-Cell Lymphoma (DLBCL)".BLOOD 142.(2023)